Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Gilmour

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Medicinal Chemistry|May 27, 2014
Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compoundJames B Thomas, Angela M Giddings, Robert W Wiethe, et al.
Journal of Medicinal Chemistry|May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonistsChad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Journal of Medicinal Chemistry|August 27, 2014
Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2James B Thomas, Angela M Giddings, Robert W Wiethe, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2014
Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2James B Thomas, Angela M Giddings, Srinivas Olepu, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
Psychopharmacology|April 1, 2010
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodentsD Matthew Walentiny, Robert E Vann, Jonathan A Warner, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Medicinal Chemistry|May 27, 2014
Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compoundJames B Thomas, Angela M Giddings, Robert W Wiethe, et al.
Journal of Medicinal Chemistry|May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonistsChad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Journal of Medicinal Chemistry|August 27, 2014
Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2James B Thomas, Angela M Giddings, Robert W Wiethe, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2014
Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2James B Thomas, Angela M Giddings, Srinivas Olepu, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
Psychopharmacology|April 1, 2010
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodentsD Matthew Walentiny, Robert E Vann, Jonathan A Warner, et al.
Pageof 3